Growth hormone deficiency and related disorders: insights into causation, diagnosis, and treatment (Q35803398)

10 August 2017

1 reference

title

Growth hormone deficiency and related disorders: insights into causation, diagnosis, and treatment (English)

1 reference

growth hormone deficiency

10 August 2017

1 reference

1

Mehul Dattani

1 reference

10 August 2017

Michael Preece

2

1 reference

PubMed ID

15194259

10 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

10 August 2017

1 reference

10 August 2017

363

1 reference

10 August 2017

9425

1 reference

10 August 2017

1977-1987

1 reference

Fetal programming of coronary heart disease

10 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Infancy Growth Pattern Related to Growth Hormone Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

On the modelling of human growth

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

The strengths and limitations of parental heights as a predictor of attained height

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Utah Growth Study: growth standards and the prevalence of growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Growth hormone therapy for the short normal child: who needs it and who wants it? The case against growth hormone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Poor growth in school entrants as an index of organic disease: the Wessex growth study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

A dominant-negative mutation of the growth hormone receptor causes familial short stature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Partial growth-hormone insensitivity: the role of growth-hormone receptor mutations in idiopathic short stature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Signaling and transcriptional mechanisms in pituitary development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

How many homeobox genes does it take to make a pituitary gland?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Multistep control of pituitary organogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Multistep signaling requirements for pituitary organogenesis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Early steps in pituitary organogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

In situ hybridization analysis of anterior pituitary hormone gene expression during fetal mouse development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Growth hormone secretion in children determined by time series analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Regulatory mechanisms of growth hormone secretion are sexually dimorphic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Ghrelin strongly stimulates growth hormone release in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

DNase I-hypersensitive sites I and II of the human growth hormone locus control region are a major developmental activator of somatotrope gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Pit-1 binding sites at the somatotrope-specific DNase I hypersensitive sites I, II of the human growth hormone locus control region are essential for in vivo hGH-N gene activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Growth Hormone Heterogeneity: Genes, Isohormones, Variants, and Binding Proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Molecular mechanism of growth hormone action

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Differences in physical characteristics, perinatal histories, and social backgrounds between children with growth hormone deficiency and constitutional short stature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

European audit of current practice in diagnosis and treatment of childhood growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

The molecular basis for developmental disorders of the pituitary gland in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Molecular basis of combined pituitary hormone deficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Autosomal dominant growth hormone deficiency disrupts secretory vesicles in vitro and in vivo in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

An exon splice enhancer mutation causes autosomal dominant GH deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Growth and endocrine sequelae of craniopharyngioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Growth in children with craniopharyngioma following surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Growth and endocrine disorders in multisystem Langerhans' cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Endocrine deficit after fractionated total body irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Growth of infants with neonatal growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure. The International Board of the Kabi Pharmacia International Growth Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

An assessment of growth hormone provocation tests

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Diagnosis and treatment of growth hormone deficiency in children and adolescents: towards a consensus. Ten years after the Availability of Recombinant Human Growth Hormone Workshop held in Pisa, Italy, 27-28 March 1998

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 1: diagnosis of growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Hazards of pharmacological tests of growth hormone secretion in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Results of early reevaluation of growth hormone secretion in short children with apparent growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Failure of IGF-I and IGFBP-3 to diagnose growth hormone insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Magnetic resonance imaging of the hypothalamic-pituitary axis in the diagnosis of growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Diagnostic value of pituitary MRI in differentiation of children with normal growth hormone secretion, isolated growth hormone deficiency and multiple pituitary hormone deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Pituitary magnetic resonance imaging and function in patients with growth hormone deficiency with and without mutations in GHRH-R, GH-1, or PROP-1 genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Reduction of the pituitary GH releasable pool in short children with GH neurosecretory dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Dosing of growth hormone in growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Diagnosis and management of growth hormone deficiency in childhood and adolescence--part 2: growth hormone treatment in growth hormone deficient children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Final height in children with idiopathic growth hormone deficiency treated with recombinant human growth hormone: the Belgian experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Growth hormone in growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Birth weight affects final height in patients treated for growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

GH and GnRH analog treatment in children who enter puberty at short stature.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Growth hormone treatment in patients with neurosecretory dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Multicenter clinical trial to evaluate the therapeutic use of recombinant growth hormone from mammalian cells in the treatment of growth hormone neurosecretory dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Clinical aspects of growth hormone deficiency in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Reduced bone mineral content in adult patients with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Growth hormone deficiency and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Decreased psychological well-being in adult patients with growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Premature mortality due to cardiovascular disease in hypopituitarism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Treatment of growth hormone deficiency in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Diagnosis and management of growth hormone deficiency in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Beneficial effects of growth hormone treatment in GH-deficient adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Human growth hormone replacement therapy: pharmacological and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

The psychological consequences and quality of life in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

The assessment of growth hormone deficiency in children and adults with particular reference to the transitional period

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Why retest young adults with childhood-onset growth hormone deficiency?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Insulin-like growth factors and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Growth hormone and tumour recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Risk of leukemia after treatment with pituitary growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Growth hormone treatment and neoplasia-coincidence or consequence?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Relationship of growth hormone deficiency and leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Update of guidelines for the use of growth hormone in children: the Lawson Wilkins pediatric endocrinology society drug and therapeutics committee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Complications of growth hormone therapy in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Effect of long-term growth hormone treatment on carbohydrate metabolism in children with growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Short stature by mutant growth hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Molecular basis of inherited growth hormone resistance in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Laron syndrome: typical and atypical forms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Growth hormone insensitivity associated with a STAT5b mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Treatment of growth hormone insensitivity syndrome (GHIS) with insulin-like growth factor (IGF-I).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Growth hormone therapy of Turner's syndrome: beneficial effect on adult height

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Four decades of growth hormone therapy for short children: what have we achieved?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genentech Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

The psychosocial consequences of short stature: a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Personality functioning: the influence of stature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Adjustment in conditions with short stature: a conceptual framework

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Uk audit of childhood growth hormone prescription, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

Obesity and stature in adolescence and earnings in young adulthood. Analysis of a British birth cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916413-1

7 January 2021

10.1016/S0140-6736(04)16413-1

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15194259